$A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction$

A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction

A model for predicting the prognosis of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) is currently not available. This study aimed to develop an age-biomarker-clinical history prognostic index (ABC-PI) and validate it for the assessment of individual prognosis.

Bibliographic Details
Main Authors:	Li Hao, Cui Yuan, Tian Jin, Yang Hong, Zhang Qing, Wang Ke, Han Qinghua, Zhang Yanbo
Format:	Article
Language:	English
Published:	De Gruyter 2020-07-01
Series:	Open Medicine
Subjects:	hfref latent trait analysis nomogram nt-probnp
Online Access:	https://doi.org/10.1515/med-2020-0209

Similar Items

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)

Laboratory Predictors of Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
by: Mariia V. Kucheriava, et al.
Published: (2023-12-01)

Left atrial reservoir strain as a predictor of cardiac outcome in patients with heart failure: the HaFaC cohort study
by: Sjoerd Bouwmeester, et al.
Published: (2022-03-01)

Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction
by: Hiroyuki Naruse, et al.
Published: (2021-08-01)

Prognostic of NT-proBNP in heart failure patients with preserved, mid and reduced ejection fraction
by: Reynie Leonel Reinoso Gonella, et al.
Published: (2021-10-01)

Heart-type fatty acid binding protein is related to severity and established cardiac biomarkers of heart failure
by: Gruson Damien, et al.
Published: (2021-07-01)

Importance of NT-pro BNP in the Prevention of Heart Failure, Left Ventricular Systolic Dysfunction and Cardiovascular Events
by: Irina CUCIUREANU, et al.
Published: (2021-06-01)

NT-proBNP as predictor of major cardiac events after renal transplantation in patients with preserved left ventricular ejection fraction
by: Sebastian Schwab, et al.
Published: (2023-02-01)

Sacubitril/valsartan improves cardiac function in Chinese patients with heart failure: a real‐world study
by: Wenwen Chen, et al.
Published: (2021-10-01)

Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis
by: Xixi Yu, et al.
Published: (2023-10-01)

N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure events
by: Giulia Ferrannini, et al.
Published: (2024-04-01)

Evaluation of Galectin-3 as a Novel Diagnostic Biomarker in Patients with Heart Failure with Preserved Ejection Fraction
by: Jyothirmayi Kanukurti, et al.
Published: (2020-08-01)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
by: Clotilde Roy, et al.
Published: (2020-10-01)

Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy
by: Karolina Weinmann, et al.
Published: (2019-10-01)

Cardiac Contractility Modulation in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction
by: Francesco Giallauria, et al.
Published: (2021-03-01)

Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
by: E M Mezhonov, et al.
Published: (2012-09-01)

Prognostic value of heart failure echocardiography index in HF patients with preserved, mid-ranged and reduced ejection fraction
by: Jian-Shu Chen, et al.
Published: (2020-07-01)

Biomarkers of heart failure: current state of problem
by: O. P. Ishevskaia, et al.
Published: (2021-12-01)

Heart Failure Probability and Early Outcomes of Critically Ill Patients With COVID-19: A Prospective, Multicenter Study
by: Weibo Gao, et al.
Published: (2021-11-01)

Resistant hypertension in elderly: a clinical manifestation of heart failure with preserved ejection fraction? retrospective single-center analysis
by: Ebru Ipek Turkoglu, et al.
Published: (2019-08-01)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
by: Carolin Gehlken, et al.
Published: (2021-08-01)

Development and Validation of a Novel Nomogram for Preoperative Prediction of In-Hospital Mortality After Coronary Artery Bypass Grafting Surgery in Heart Failure With Reduced Ejection Fraction
by: Pengyun Yan, et al.
Published: (2021-09-01)

Update on the Value of Lung Ultrasound Examination in Acute Decompensated Heart Failure Patients with Various Left Ventricular Ejection Fraction
by: Hui Zhang, et al.
Published: (2022-10-01)

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
by: Michele Senni, et al.
Published: (2022-12-01)

The Role of Congestion Biomarkers in Heart Failure with Reduced Ejection Fraction
by: Michele Correale, et al.
Published: (2023-06-01)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
by: Abdallah Al‐Mohammad
Published: (2019-08-01)

The clinical value of determination of natriuretic peptides in acute coronary syndrome
by: Ekaterina Viktorovna Shreyder, et al.
Published: (2010-09-01)

Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
by: Wei Pan, et al.
Published: (2020-04-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Clinical Prognosis in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction after Myocardial Revascularization on the Background of Taking SGLT2 Inhibitors
by: Mariia V. Kucheriava, et al.
Published: (2022-06-01)

Influence of collaterals on the left ventricular end-diastolic pressure and serum NT-proBNP levels in patients with coronary chronic total occlusion
by: Fuad Samadov, et al.
Published: (2017-06-01)

Relationship between NT-proBNP and the ejection fraction during intensive care variety in polytrauma patients with concomitant cardiac disorder
by: Svitlana Lutska, et al.
Published: (2021-10-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)

Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
by: Sha Fu, et al.
Published: (2021-06-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis
by: Birutė Gumauskienė, et al.
Published: (2018-09-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)

Assessment of prognostic markers of heart failure following acute myocardial infarction in patients treated with primary percutaneous coronary intervention
by: Marjanović Dajana, et al.
Published: (2022-01-01)

Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure
by: Murat Selçuk, et al.
Published: (2021-05-01)